People who get migraines are less likely to develop type 2 diabetes, while some people who develop diabetes become less prone to migraines. Today, scientists studying the link between these conditions report how the peptides that cause migraine pain can influence production of insulin in mice, possibly by regulating the amount of secreted insulin or by increasing the number of pancreatic cells that produce it. These findings could improve methods to prevent or treat diabetes. The researchers presented their results at the fall meeting of the American Chemical Society (ACS). ACS Fall 2021 was a hybrid meeting held virtually and in-person August 22-26, and on-demand content will be available August 30-September 30. The meeting featured more than 7,000 presentations on a wide range of science topics.